Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acorda Therapeutics Inc (NASDAQ:ACOR)

25.60
Delayed Data
As of Jul 22
 +0.19 / +0.75%
Today’s Change
23.85
Today|||52-Week Range
43.63
-40.16%
Year-to-Date

Today’s Trading

Previous close25.41
Today’s open25.46
Day’s range25.22 - 26.12
Volume302,788
Average volume (3 months)674,992
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-40.48%
Earnings growth (this year)-28.00%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+22.71%
P/E ratio83.3
Price/Sales3.79
Price/Book1.82

Competitors

 Today’s
change
Today’s
% change
ACHNAchillion Pharmaceut...-0.17-1.94%
SRPTSarepta Therapeutics...+1.24+5.47%
INSYINSYS Therapeutics I...+0.33+2.11%
LCILannett Company Inc-0.11-0.36%
Data as of 4:01pm ET, 07/22/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)$0.24
Annual revenue (last year)$492.7M
Annual profit (last year)$11.1M
Net profit margin2.24%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Head-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts

Partner Offers

Search for Jobs